Changes in Plasma Homocyst(e)ine in the Acute Phase After Stroke

Background and Purpose—; Elevated plasma homocyst(e)ine [H(e)] concentration has been associated with an increased risk of stroke. Although the literature suggests that H(e) increases from the acute to the convalescent phase after a stroke, it is not known whether H(e) changes within the acute period. Methods—; A prospective, multicenter study was conducted to examine changes in H(e) during the 2 weeks after an incident stroke. Blood samples were collected at days 1, 3, 5, 7, and between 10 and 14 days after the stroke. Results—; Seventy-six participants (51 men) were enrolled from 9 sites from February 1997 through June 1998. Mean age was 65.6 years, and subjects had at least two H(e) measurements. The estimated mean H(e) level at baseline was 11.3±0.5 &mgr;mol/L, which increased consistently to a mean of 12.0±0.05, 12.4±0.5, 13.3±0.5, and 13.7±0.7 &mgr;mol/L at days 3, 5, 7, and 10 to 14, respectively. The magnitude of the change in H(e) was not affected by age, sex, smoking status, alcohol use, history of hypertension or diabetes, or Rankin Scale Score. Conclusions—; These data suggest that the clinical interpretation of H(e) after stroke and the eligibility for clinical trials assessing treatment for elevated H(e) levels require an adjustment in time since stroke to properly interpret the observed H(e) levels.

[1]  R. Andersen,et al.  OBESITY AND ITS RELATIONSHIP TO MARITAL STATUS IN US ADULTS. RESULTS FROM THE THIRD NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY, 1988-1994 , 2001 .

[2]  P. Ueland,et al.  Plasma Total Homocysteine Is Influenced by Prandial Status in Humans: The Hordaland Homocysteine Study 1 , 2001 .

[3]  M. Noble,et al.  Acute and convalescent changes in plasma homocysteine concentrations in acute coronary syndromes , 2001, Heart.

[4]  J. David Spence,et al.  Vitamin Intervention for Stroke Prevention (VISP) Trial: Rationale and Design , 2001, Neuroepidemiology.

[5]  P. Wolf,et al.  Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. , 2001, Circulation.

[6]  M. Greaves,et al.  Plasma Homocysteine Concentrations in the Acute and Convalescent Periods of Atherothrombotic Stroke , 2001, Stroke.

[7]  J. Møller,et al.  A meta-analysis of cerebrovascular disease and hyperhomocysteinaemia. , 2000, Scandinavian journal of clinical and laboratory investigation.

[8]  J. Nagendran,et al.  Elevation of plasma homocysteine levels associated with acute myocardial infarction. , 2000, Clinical and investigative medicine. Medecine clinique et experimentale.

[9]  D. Wilcken,et al.  Homocysteine and cardiovascular disease: cause or effect? , 2000, The American journal of clinical nutrition.

[10]  R. Glynn,et al.  Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual? , 2000, Archives of internal medicine.

[11]  R. D'Agostino,et al.  Nonfasting Plasma Total Homocysteine Levels and Stroke Incidence in Elderly Persons: The Framingham Study , 1999, Annals of Internal Medicine.

[12]  S. Yusuf,et al.  Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence , 1999, Annals of Internal Medicine.

[13]  Christopher M Thomas,et al.  Dietary folate from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in a dietary controlled trial. , 1999, The Journal of nutrition.

[14]  J. Malm,et al.  Hyperhomocysteinemia and hypofibrinolysis in young adults with ischemic stroke. , 1999, Stroke.

[15]  S. Kittner,et al.  Total homocyst(e)ine concentration and the likelihood of nonfatal stroke: results from the Third National Health and Nutrition Examination Survey, 1988-1994. , 1998, Stroke.

[16]  C. Chung,et al.  Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis. , 1998, Stroke.

[17]  R. Collins,et al.  Can Dietary Supplements with Folic Acid or Vitamin B6 Reduce Cardiovascular Risk? Design of Clinical Trials to Test the Homocysteine Hypothesis of Vascular Disease , 1998, Journal of cardiovascular risk.

[18]  R. Brant,et al.  Fluctuations in blood lipid levels during furosemide therapy: a randomized, double-blind, placebo-controlled crossover study. , 1998, Archives of internal medicine.

[19]  R. Sacco,et al.  Homocysteine as a Risk Factor for Ischemic Stroke: An Epidemiological Story in Evolution , 1998, Neuroepidemiology.

[20]  H. Blom,et al.  Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials , 1998, BMJ.

[21]  R. Crooks,et al.  Serial measures of plasma homocyst(e)ine after acute myocardial infarction. , 1996, The American journal of cardiology.

[22]  G. Omenn,et al.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.

[23]  B. Norrving,et al.  Plasma homocysteine in the acute and convalescent phases after stroke. , 1995, Stroke.

[24]  A. Lindgren,et al.  Plasma homocysteine in acute myocardial infarction: homocysteine‐lowering effect of folic acid , 1995, Journal of internal medicine.

[25]  W. Vermaak,et al.  The effect of blood sample aging and food consumption on plasma total homocysteine levels. , 1992, Clinica chimica acta; international journal of clinical chemistry.

[26]  M. Malinow,et al.  Homocyst(e)inemia in daily practice: levels in coronary artery disease , 1990 .

[27]  L. Taylor,et al.  Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. , 1989, Circulation.

[28]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[29]  P A Wolf,et al.  Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. , 2001, Circulation.

[30]  K. Furie,et al.  Mild-to-moderate hyperhomocyst(e)inemia and risk of stroke. Result of a meta-analysis. , 2000 .

[31]  S. Grundy,et al.  Increases in serum lipid and lipoprotein levels with movement from the supine to standing position in adult men and women. , 1986, Preventive medicine.

[32]  N. Tietz Fundamentals of Clinical Chemistry , 1970 .